Articles From: Aaron's, Inc. Statement on Vintage Capital Management Unsolicited Offer to AB InBev Posts Surge in Net Profit


2014/2/7
ATLANTA , Feb.
Sign-up for Aaron's, Inc. Statement on Vintage Capital Management Unsolicited Offer investment picks
2013/10/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0905036001&sourceType=1 http://www.ccnmatthews.com/logos/20110627-3%20PMS%20COLORS%20GRADIENTaastra200.jpg TORONTO, ONTARIO --
Sign-up for Aastra Reports Third Quarter Financial Results investment picks
2014/4/1
ANN ARBOR, Mich., April 1, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced the appointments of Ross Tubo, PhD, as chief scientific officer and David Recker, MD, FACR, FACP, as chief medical officer of Aastrom.
Sign-up for Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer investment picks
2013/11/1
ANN ARBOR, Mich., Nov.
Sign-up for Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & Therapy investment picks
2013/8/12
ANN ARBOR, Mich., Aug.
Sign-up for Aastrom Biosciences Announces Amendment of Series B Preferred Stock Certificate of Designations, Preferences and Rights investment picks
ANN ARBOR, Mich., Oct.
Sign-up for Aastrom Biosciences Announces One-for-Twenty Reverse Stock Split investment picks
2014/1/27
ANN ARBOR, Mich., Jan.
Sign-up for Aastrom Biosciences Enters Into $15 Million Equity Commitment With Lincoln Park Capital investment picks
ANN ARBOR, Mich., Dec.
Sign-up for Aastrom Biosciences Granted Composition-of-Matter Patent for Ixmyelocel-T in Australia investment picks
2013/10/16
ANN ARBOR, Mich., Oct.
Sign-up for Aastrom Biosciences One-for-Twenty Reverse Stock Split Now Effective investment picks
ANN ARBOR, Mich., Nov.
Sign-up for Aastrom Biosciences Regains Compliance With NASDAQ Equity Standard Listing Requirement investment picks
ANN ARBOR, Mich., Oct.
Sign-up for Aastrom Biosciences Regains Compliance With NASDAQ Minimum Bid Requirement investment picks
2014/3/13
ANN ARBOR, Mich., March 13, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today reported financial results for the fourth quarter and year ended December 31, 2013.
Sign-up for Aastrom Biosciences Reports Fourth-Quarter and Year-End 2013 Financial Results investment picks
ANN ARBOR, Mich., Aug.
Sign-up for Aastrom Biosciences Reports Second-Quarter and First-Half 2013 Financial Results investment picks
2013/11/12
ANN ARBOR, Mich., Nov.
Sign-up for Aastrom Biosciences Reports Third-Quarter and Nine-Month 2013 Financial Results investment picks
2014/3/6
ANN ARBOR, Mich., March 6, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast: If you are unable to participate during the live call, the webcast will be available at http://investors.aastrom.com/events.cfm  until March 13, 2015.
Sign-up for Aastrom Biosciences to Host Fourth Quarter 2013 Investor Call on March 13, 2014 investment picks
ANN ARBOR, Mich., Nov.
Sign-up for Aastrom Biosciences to Host Third Quarter 2013 Investor Call on November 12, 2013 investment picks
2013/10/10
ANN ARBOR, Mich., Oct.
Sign-up for Aastrom Biosciences to Present at the 2013 Stem Cell Meeting on the Mesa Conference investment picks
2013/11/12
ANN ARBOR, Mich., Nov.
Sign-up for Aastrom Biosciences to Present at the 2013 Therapeutic Area Partnerships Conference investment picks
2014/3/19
ANN ARBOR, Mich., March 19, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that Nick Colangelo, President and CEO of Aastrom, will present at the 2014 Regen Med Investor Day on Wednesday, March 26 at 3:15 p.m. EDT at the Metropolitan Club in New York City.
Sign-up for Aastrom Biosciences to Present at the 2014 Regen Med Investor Day investment picks
2013/9/19
ANN ARBOR, Mich., Sept.
Sign-up for Aastrom Biosciences to Present at the Aegis Capital 2013 Healthcare Conference investment picks
2013/8/16
ANN ARBOR, Mich., Aug.
Sign-up for Aastrom Biosciences, Inc. Announces Closing of Public Offering of Common Stock and Warrants investment picks
2013/8/13
ANN ARBOR, Mich., Aug.
Sign-up for Aastrom Biosciences, Inc. Announces Pricing of Public Offering of Common Stock and Warrants investment picks
2013/9/16
ANN ARBOR, Mich., Sept.
Sign-up for Aastrom Clinical Trial Application for Phase 2b ixCELL-DCM Study of ixmyelocel-T Approved in Canada investment picks
2014/4/9
ANN ARBOR, Mich., April 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that the independent Data and Safety Monitoring Board (DSMB) for the company's ixCELL-DCM Phase 2b clinical trial has recommended continuing the study without modification as planned following an interim review of unblinded safety data from the trial.
Sign-up for Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial investment picks
2014/1/16
By Jana Weigand LONDON--Associated British Foods PLC (ABF.LN), a food and retail company, Thursday reported bumper Christmas sales at budget clothing chain Primark but said trading at its sugar business was weaker than expected.
Sign-up for AB Foods Posts Strong Christmas Sales at Primark, Sugar Weaker Than Expected investment picks
By Ian Walker LONDON--Clothing and food retailer Associated British Foods PLC (ABF.LN) said Friday that trade for the first two months of fiscal 2014 was in line with expectations, with further growth in like-for-like sales at discount fashion retailer Primark.
Sign-up for AB Foods Sales in Line with Expectations, Sees More Growth from Primark investment picks
2014/1/17
By Dana Cimilluca and Mike Esterl Beer behemoth Anheuser-Busch InBev SA is nearing a deal to reacquire leading South Korean brewer Oriental Brewery from KKR & Co.
Sign-up for AB Inbev Nearing $4.5 Billion Deal to Reacquire Oriental Brewery -- Update investment picks
2014/1/17
By Dana Cimilluca and Mike Esterl Beer behemoth Anheuser-Busch InBev SA is nearing a deal to reacquire leading South Korean brewer Oriental Brewery from KKR & Co.
Sign-up for AB Inbev Nearing $4.5 Billion Deal to Reaquire Oriental Brewery investment picks
BRUSSELS-- Anheuser-Busch InBev on Wednesday reported a 47% increase fourth-quarter profit, driven by strong performance Brazil and cost cutting in Mexico in the wake of the company's takeover of brewer Grupo Modelo.
Sign-up for AB InBev Posts Surge in Net Profit investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Aaron's, Inc. Statement on Vintage Capital Management Unsolicited Offer to AB InBev Posts Surge in Net Profit
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity